Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Work
Year: 2019
Type: article
Abstract: Preclinical data have suggested that nintedanib, an intracellular inhibitor of tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the efficacy of nintedanib ha... more
Source: New England Journal of Medicine
Institutions University of Michigan–Ann Arbor, Lung Institute, Royal Brompton & Harefield NHS Foundation Trust, National Institute for Health Research, Université Claude Bernard Lyon 1 +14 more
Cites: 26
Cited by: 1,690
Related to: 10
FWCI: 176.4
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze
Funder Boehringer Ingelheim